Keywords: roche/gsk, launches, bonviva, swiss, drug, major, roche
Roche/GSK launches Bonviva
Article | 08 May 2006
Swiss drug major Roche and GlaxoSmithKline have launched the first intravenous bisphosphonate injection for the treatment of postmenopausal osteoporosis. Bonviva 3 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
